Back to Search
Start Over
[Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
- Source :
-
Clinical calcium [Clin Calcium] 2004 May; Vol. 14 (5), pp. 731-7. - Publication Year :
- 2004
-
Abstract
- Hyperparathyroidism, renal osteodystrophy and ectopic calcification, caused by hypocalcemia and hyperphosphatemia, are important complication in renal dysfunction, especially in end stage renal disease. Because it is the reason for reducing the survival rate and quality of life in these patients, it is important to control them from early stage in renal dysfunction. K/DOQI (kidney disease outcomes quality initiative) guideline shows us the recommended practical level and its account. It may be helpful for our daily clinical work.
- Subjects :
- Calcinosis etiology
Calcinosis prevention & control
Calcium Carbonate therapeutic use
Calcium, Dietary administration & dosage
Chronic Kidney Disease-Mineral and Bone Disorder etiology
Chronic Kidney Disease-Mineral and Bone Disorder prevention & control
Epoxy Compounds therapeutic use
Evidence-Based Medicine
Humans
Hyperparathyroidism, Secondary etiology
Hyperparathyroidism, Secondary prevention & control
Kidney Failure, Chronic complications
Phosphorus, Dietary administration & dosage
Polyamines
Polyethylenes therapeutic use
Sevelamer
Calcium blood
Kidney Failure, Chronic blood
Kidney Failure, Chronic therapy
Parathyroid Hormone blood
Phosphorus blood
Practice Guidelines as Topic
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0917-5857
- Volume :
- 14
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Clinical calcium
- Publication Type :
- Academic Journal
- Accession number :
- 15577034
- Full Text :
- https://doi.org/CliCa0405731737